The global Cerebral Somatic Oximeters Market, By Product Type (Dual Emitter and Dual Detector, Single Emitter and Dual Detector, and Others), By Patient Type (Pediatrics, Adults, and Others) By Application (Cardiac Surgery, Vascular Surgery, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 150.1 million in 2019, and is expected to exhibit a CAGR of 7.9%, during the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.

The increasing prevalence of neurological disorders and brain trauma have led to high demand for cerebral somatic oximeters. This increase in demand has led major players in the market to introduce technologically advanced cerebral somatic oximeters which would require regulatory approval from regulatory authorities. These factors are expected to propel growth of the cerebral somatic oximeters market. For instance, For instance, in June 2019, Masimo Corporation received the U.S. Food and Drug Administration approval for its O3 Regional Oximetry for neonates. The O3 System is designed to assist clinicians in monitoring cerebral oxygenation in cases where peripheral pulse oximetry cannot be used alone to monitor brain oxygenation.

Browse 48 Market Data Tables and 38 Figures spread through 165 Pages and in-depth TOC on Cerebral Somatic Oximeters Market, By Product Type (Dual Emitter and Dual Detector, Single Emitter and Dual Detector, and Others), By Patient Type (Pediatrics, Adults, and Others) By Application (Cardiac Surgery, Vascular Surgery, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027'

To know the latest trends and insights related to Cerebral Somatic Oximeters Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/cerebral-somatic-oximeters-market-2659

The increasing number of product launches is expected to facilitate growth of the global cerebral somatic oximeters market during the forecast period. For instance, in September 2016, ISS, Inc. developed and introduced OxiplexTS200 which is the clinical version of non-invasive tissue oximeter for the measurement of oxy and deoxy hemoglobin concentration and oxygen saturation in tissues. Oxiplex TS200 contains four emitter positions with eight emitters.

Moreover, increase in demand for technologically advanced and efficient cerebral oximeters is expected to provide growth opportunities for industry players. For instance, in December 2019, Masimo Corporation and Dräger, a Germany-based breathing and protection equipment manufacturing company, expanded their partnership for brain monitoring. According to the agreement, Dräger will integrate additional Masimo measurement technologies to help clinicians assess brain function, oxygenation, and ventilation status.

Key Takeaways of the Global Cerebral Somatic Oximeters Market:

  • The global cerebral somatic oximeters market is expected to exhibit a CAGR of 7.9% during the forecast period (2019-2027) owing to the increasing incidence of cardiovascular disorders such as congestive heart failure (CHF) and stroke in adults. For instance, according to the American Heart Association report published in January 2019, stroke is a leading cause of death in the U.S. with around 800,000 people suffering a stroke in the U.S. annually due to blockage in blood vessels which supply blood to the brain in adult patients.
  • Furthermore, increasing research and development of innovative products is expected to drive the segment growth. For instance, in May 2017, Medtronic Plc. and National Institutes of Health (NIH) has collaboratively have conducted a clinical study for development of next generation cerebral and tissue oximeter to measure cerebral and somatic tissue oxygen saturation in healthy volunteers
  • Major players operating in the global cerebral somatic oximeters market include Medtronic plc., Nonin, Edwards Lifesciences Corporation, ISS, Inc., Masimo Corporation, Hamamatsu Photonics K.K., and Mespere LifeSciences.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner